Clinical Trials Browser

Phase 2 × Hemangiosarcoma × Albumin-Bound Paclitaxel × Clear all

NCT01055028 2018-03-26

Paclitaxel + Bevacizumab (Avastin) for the Treatment of Metastatic or Unresectable Angiosarcoma

Phase 2 Terminated

18 enrolled 13 charts

Hemangiosarcoma, Sarcoma